NEW PRODUCT 

RNA from 100% pure Cor.At cardiomyocytes of two different maturation stages is now available. For more information please contact us. Click here!

 
 

µEST 

is an innovative in vitro embryonic stem cell (ESC) assay for evaluating the embryotoxicity and teratogenicity of drugs and other compounds. More ...

 

NEWS & MEDIA

  • Transfection protocol für Cor.At pure cardiomyocytes using Amaxa's nucleofection technology is now available.
  • New Paper: "Preclinical assessment of cardiac toxicity with pure cardiomycocytes" published in Drug Discovery Today (2008 Aug 13, 702-7)
  • Download our recent presentation at the World Pharma Congress: "ES-cell derived systems in drug development and toxicology"

CONTACT

AXIOGENESIS AG
Nattermannalle 1 / S 20
50829 Cologne
Germany
info@axiogenesis.com